FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Bliska

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Concepts & Ideas

Virulence

Disorders

Physiology

Procedures

Microbial Colony Count

Co-author Network

Publications

TOP 3
David G Thanassi; James B Bliska; Peter J Christie
Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.
Matthew Hatkoff; Indralatha Jayatilaka; Celine Pujol; Lisa M Runco; James B Bliska; Martha B Furie; David G Thanassi
Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells.
Joseph B McPhee; Patricio Mena; Yue Zhang; James B Bliska
Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Bliska (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: David G Thanassi; James B Bliska; Peter J Christie
Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.
FEMS microbiology reviews 2012;36(6):1046-82.
2012: Matthew Hatkoff; Indralatha Jayatilaka; Celine Pujol; Lisa M Runco; James B Bliska; Martha B Furie; David G Thanassi
Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells.
Infection and immunity 2012;80(10):3490-500.
2012: Joseph B McPhee; Patricio Mena; Yue Zhang; James B Bliska
Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
Infection and immunity 2012;80(7):2519-27.
2012: Suqing Zheng; Ying Zheng; James B Bliska; Ronald Bumeister; Emilie David; Albena T Dinkova-Kostova; Dale F Mierke; Iwao Ojima; Yanqing Ren; Y R Santosh Laxmi; Katherine H Shiavoni; Isaac Trevino; W Christian Wigley; Tadashi Honda
Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents.
Journal of medicinal chemistry 2012;55(10):4837-46.
2012: Kathryn A Klein; Lance E Palmer; Mark Pelletier; Galina Romanov; Robert Ernst; Hana S Fukuto; Jens P Grabenstein; James B Bliska
A transposon site hybridization screen identifies galU and wecBC as important for survival of Yersinia pestis in murine macrophages.
Journal of bacteriology 2012;194(3):653-62.
2012: James B Bliska; Adrianus W M van der Velden
Salmonella "sops" up a preferred electron receptor in the inflamed intestine.
mBio 2012;3(4):e00226-12.
2012: Ying Zheng; Sarit Lilo; Patricio Mena; James B Bliska
YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense.
PloS one 2012;7(4):e36019.
2011: Yue Zhang; Galina Romanov; James B Bliska
Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.
Infection and immunity 2011;79(11):4322-31.
2011: Ying Zheng; Sarit Lilo; Igor E Brodsky; Yue Zhang; Ruslan Medzhitov; Kenneth B Marcu; James B Bliska
A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.
PLoS pathogens 2011;7(4):e1002026.
2011: Yue Zhang; James B Bliska
Mathematical relationship between cytokine concentrations and pathogen levels during infection.
Cytokine 2011;53(2):158-62.
2011: Rodrigo Torres; Nicole Wheatley; Rommie E Amaro; Brian R Atwood; James B Bliska; Nicholas Chim; Benson Lan; Céline Pujol; Banu Sankaran; Robert V Swift; Celia W Goulding
Biochemical, structural and molecular dynamics analyses of the potential virulence factor RipA from Yersinia pestis.
PloS one 2011;6(9):e25084.
2010: Jr-Shiuan Lin; Steven Park; Jeffrey J Adamovicz; Jim Hill; James B Bliska; Christopher K Cote; David S Perlin; Kei Amemiya; Stephen T Smiley
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
Vaccine 2010;29(2):357-62.
2010: Hana S Fukuto; Anton Svetlanov; Lance E Palmer; A Wali Karzai; James B Bliska
Global gene expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative stress-induced operon in regulating type III secretion and intracellular cell division.
Infection and immunity 2010;78(9):3700-15.
2010: Joseph B McPhee; Patricio Mena; James B Bliska
Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence.
Infection and immunity 2010;78(8):3529-39.
2010: Igor E Brodsky; Noah W Palm; Saheli Sadanand; Michelle B Ryndak; Fayyaz S Sutterwala; Richard A Flavell; James B Bliska; Ruslan Medzhitov
A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system.
Cell host & microbe 2010;7(5):376-87.
2010: Yue Zhang; James B Bliska
YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Infection and immunity 2010;78(5):2329-41.
2010: Nihal A Okan; Patricio Mena; Jorge L Benach; James B Bliska; A Wali Karzai
The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection.
Infection and immunity 2010;78(3):1284-93.
2009: Betty L Noel; Sarit Lilo; Daniel Capurso; Jim Hill; James B Bliska
Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.
Clinical and vaccine immunology : CVI 2009;16(10):1457-66.
2009: Kathryn A Klein; James B Bliska
How Yersinia pestis becomes a foreign obstruction in the digestive system of the macrophage.
Autophagy 2009;5(6):882-3.
2009: Céline Pujol; Kathryn A Klein; Galina A Romanov; Lance E Palmer; Carol Cirota; Zijiang Zhao; James B Bliska
Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification.
Infection and immunity 2009;77(6):2251-61.
2009: James B Bliska; Arturo Casadevall
Intracellular pathogenic bacteria and fungi--a case of convergent evolution?
Nature reviews. Microbiology 2009;7(2):165-71.
2008: Maya I Ivanov; Betty L Noel; Ryan Rampersaud; Patricio Mena; Jorge L Benach; James B Bliska
Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis.
Infection and immunity 2008;76(11):5181-90.
2008: Yue Zhang; James Murtha; Margaret A Roberts; Richard Siegel; James B Bliska
Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
Infection and immunity 2008;76(9):4299-310.
2008: Sarit Lilo; Ying Zheng; James B Bliska
Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ.
Infection and immunity 2008;76(9):3911-23.
2008: Lisa M Runco; Selina Myrczek; James B Bliska; David G Thanassi
Biogenesis of the fraction 1 capsule and analysis of the ultrastructure of Yersinia pestis.
Journal of bacteriology 2008;190(9):3381-5.
2008: Edison Mejía; James B Bliska; Gloria I Viboud
Yersinia controls type III effector delivery into host cells by modulating Rho activity.
PLoS pathogens 2008;4(1):e3.
2006: Gerd Prehna; Maya I Ivanov; James B Bliska; C Erec Stebbins
Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors.
Cell 2006;126(5):869-80.
2006: Gloria I Viboud; Edison Mejía; James B Bliska
Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Cellular microbiology 2006;8(9):1504-15.
2006: James B Bliska
Yersinia inhibits host signaling by acetylating MAPK kinases.
ACS chemical biology 2006;1(6):349-51.
2006: Jens P Grabenstein; Hana S Fukuto; Lance E Palmer; James B Bliska
Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of Yersinia pestis in macrophages.
Infection and immunity 2006;74(7):3727-41.
2006: Nihal A Okan; James B Bliska; A Wali Karzai
A Role for the SmpB-SsrA system in Yersinia pseudotuberculosis pathogenesis.
PLoS pathogens 2006;2(1):e6.
2005: Krischan J Hudson; James B Bliska; Amy H Bouton
Distinct mechanisms of integrin binding by Yersinia pseudotuberculosis adhesins determine the phagocytic response of host macrophages.
Cellular microbiology 2005;7(10):1474-89.
2005: Céline Pujol; Jens P Grabenstein; Robert D Perry; James B Bliska
Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(36):12909-14.
2005: Yue Zhang; Adrian T Ting; Kenneth B Marcu; James B Bliska
Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(12):7939-49.
2005: Michelle B Ryndak; Hachung Chung; Erwin London; James B Bliska
Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein.
Infection and immunity 2005;73(4):2433-43.
2005: Céline Pujol; James B Bliska
Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae.
Clinical immunology (Orlando, Fla.) 2005;114(3):216-26.
2005: Maya I Ivanov; Jeanne A Stuckey; Heidi L Schubert; Mark Saper; James B Bliska
Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence.
Molecular microbiology 2005;55(5):1346-56.
2005: Maria J C Gomes-Solecki; Anne G Savitt; Rebecca Rowehl; John D Glass; James B Bliska; Raymond J Dattwyler
LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples.
Clinical and diagnostic laboratory immunology 2005;12(2):339-46.
2005: Gloria I Viboud; James B Bliska
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.
Annual review of microbiology 2005;59():69-89.
2005: Yue Zhang; James B Bliska
Role of macrophage apoptosis in the pathogenesis of Yersinia.
Current topics in microbiology and immunology 2005;289():151-73.
2004: Jens P Grabenstein; Michael Marceau; Céline Pujol; Michel Simonet; James B Bliska
The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
Infection and immunity 2004;72(9):4973-84.
2004: Deepannita Roy; David R Liston; Vincent J Idone; Anke Di; Deborah J Nelson; Céline Pujol; James B Bliska; Sabyasachi Chakrabarti; Norma W Andrews
A process for controlling intracellular bacterial infections induced by membrane injury.
Science (New York, N.Y.) 2004;304(5676):1515-8.
2003: Fubo Liang; Zhonghui Huang; Seung-Yub Lee; Jiao Liang; Maya I Ivanov; Andres Alonso; James B Bliska; David S Lawrence; Tomas Mustelin; Zhong-Yin Zhang
Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague.
The Journal of biological chemistry 2003;278(43):41734-41.
2003: Céline Pujol; James B Bliska
The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis.
Infection and immunity 2003;71(10):5892-9.
2003: Christine McDonald; Panayiotis O Vacratsis; James B Bliska; Jack E Dixon
The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases.
The Journal of biological chemistry 2003;278(20):18514-23.
2003: Gloria I Viboud; Stephane Shu Kin So; Michelle B Ryndak; James B Bliska
Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Molecular microbiology 2003;47(5):1305-15.
2003: Yue Zhang; James B Bliska
Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection.
Infection and immunity 2003;71(3):1513-9.
2002: Gloria I Viboud; James B Bliska
Measurement of pore formation by contact-dependent type III protein secretion systems.
Methods in enzymology 2002;358():345-50.
2001: Gloria I Viboud; James B Bliska
A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes.
The EMBO journal 2001;20(19):5373-82.
2001: L G Montagna; Maya I Ivanov; James B Bliska
Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition.
The Journal of biological chemistry 2001;276(7):5005-11.
2000: Cheryl L Weidow; DS Black; James B Bliska; Amy H Bouton
CAS/Crk signalling mediates uptake of Yersinia into human epithelial cells.
Cellular microbiology 2000;2(6):549-60.
2000: Kim Orth; Zhaohui Xu; Mary Beth Mudgett; Zhao Qin Bao; Lance E Palmer; James B Bliska; W F Mangel; Brian J Staskawicz; Jack E Dixon
Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.
Science (New York, N.Y.) 2000;290(5496):1594-7.
2000: DS Black; Anne Marie-Cardine; B Schraven; James B Bliska
The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages.
Cellular microbiology 2000;2(5):401-14.
2000: DS Black; James B Bliska
The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.
Molecular microbiology 2000;37(3):515-27.
1999: Kim Orth; Lance E Palmer; Zhao Qin Bao; Scott Stewart; AE Rudolph; James B Bliska; Jack E Dixon
Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.
Science (New York, N.Y.) 1999;285(5435):1920-3.
1999: Lance E Palmer; A R Pancetti; S Greenberg; James B Bliska
YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells.
Infection and immunity 1999;67(2):708-16.
1998: DS Black; L G Montagna; S Zitsmann; James B Bliska
Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets.
Molecular microbiology 1998;29(5):1263-74.
1998: Lance E Palmer; S Hobbie; J E Galán; James B Bliska
YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK.
Molecular microbiology 1998;27(5):953-65.
1997: DS Black; James B Bliska
Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions.
The EMBO journal 1997;16(10):2730-44.
1996: K Kaniga; J Uralil; James B Bliska; Jorge E Galán
A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium.
Molecular microbiology 1996;21(3):633-41.
1996: Jorge E Galán; James B Bliska
Cross-talk between bacterial pathogens and their host cells.
Annual review of cell and developmental biology 1996;12():221-55.
1996: James B Bliska
How pathogens exploit interactions mediated by SH3 domains.
Chemistry & biology 1996;3(1):7-11.
1995: James B Bliska; DS Black
Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase.
Infection and immunity 1995;63(2):681-5.
1993: James B Bliska; Jorge E Galán; S Falkow
Signal transduction in the mammalian cell during bacterial attachment and entry.
Cell 1993;73(5):903-20.